Future studies will also evaluate whether treating CS‐exposed mice with TMS can reduce the progression of COPD‐like disease to further explore the potential of CYP1B1 inhibition as a therapeutic approach for COPD. The gene discussed is CYP1B1; the disease is chronic obstructive pulmonary disease.